A tailored extracellular matrix (ECM) - Mimetic coating for cardiovascular stents by stepwise assembly of hyaluronic acid and recombinant human type III collagen
Source abstract
Abstract
Collagen, a central component of the extracellular matrix (ECM), has been widely applied in tissue engineering, among others, for wound healing or bone and nerve regeneration. However, the inherent thrombogenic properties of collagen hinder the application in blood-contacting devices. Herein, a brand-new recombinant human type III collagen (hCOLIII) was explored that does not present binding sites for platelets while retaining the affinity for endothelial cells. The hCOLIII together with hyaluronic acid (HA) were deposited on the substrates via layer-by-layer assembly to form an ECM-mimetic multilayer coating. In vitro platelet adhesion and ex vivo blood circulation tests demonstrated prominent thromboprotective properties for the hCOLIII-based ECM-mimetic coating. In addition, the coating effectively guided the vascular cell fate by supporting the proliferation of endothelial cells and inhibiting the proliferation of smooth muscle cells by differentiating them to a more contractile phenotype. A polylactic acid (PLA) stent coated with hCOLIII-based ECM-mimetic coating was implanted in the abdominal aorta of rabbits to investigate the healing of the neointima. The enhanced endothelialization, suppressed inflammatory response, inhibition of excessive neointimal hyperplasia, and the superior thromboprotection strongly indicated the prospect of the hCOLIII-based ECM-mimetic coating as a tailored blood-contacting material for cardiovascular stents.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Electrospun Nanofibers in Biomedical Applications · Tissue Engineering and Regenerative Medicine · Polymer Surface Interaction Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (51)
Show source-provided references
1. Designing better cardiovascular stent materials: a learning curve10.1002/adfm.202005361 ↗
2. Mimicking the nitric oxide-releasing and glycocalyx functions of endothelium on vascular stent surfaces10.1002/advs.202002330 ↗
3. Enhanced biocompatibility of CD47-functionalized vascular stents10.1016/j.biomaterials.2016.02.008 ↗
4. Matrix-metalloproteinase-responsive gene delivery surface for enhanced in situ endothelialization10.1021/acsami.0c11971 ↗
5. The blood compatibility challenge Part 4: surface modification for hemocompatible materials: passive and active approaches to guide blood-material interactions10.1016/j.actbio.2019.06.019 ↗
6. Phenolic-amine chemistry mediated synergistic modification with polyphenols and thrombin inhibitor for combating the thrombosis and inflammation of cardiovascular stents10.1016/j.biomaterials.2020.120626 ↗
7. The prevention of restenosis in vivo with a VEGF gene and paclitaxel co-eluting stent10.1016/j.biomaterials.2012.11.006 ↗
8. Endothelial cell adhesion and blood response to hemocompatible peptide 1 (HCP-1), REDV, and RGD peptide sequences with free N-terminal amino groups immobilized on a biomedical expanded polytetrafluorethylene surface
9. The co-deposition coating of collagen IV and laminin on hyaluronic acid pattern for better biocompatibility on cardiovascular biomaterials10.1016/j.colsurfb.2020.111307 ↗
10. Improving blood-compatibility of titanium by coating collagen–heparin multilayers10.1016/j.apsusc.2009.03.011 ↗
11. Collagen: animal sources and biomedical application10.7324/JAPS.2015.50322 ↗
12. A tough PVA/HA/COL composite hydrogel with simple process and excellent mechanical properties10.1016/j.mtcomm.2019.100702 ↗
13. Synergistic interaction of platelet derived growth factor (PDGF) with the surface of PLLA/Col/HA and PLLA/HA scaffolds produces rapid osteogenic differentiation10.1016/j.colsurfb.2015.11.053 ↗
14. Carbon nanofiber reinforced nonmulberry silk protein fibroin nanobiocomposite for tissue engineering applications10.1021/acsami.6b04777 ↗
15. A conformally adapted all-in-one hydrogel coating: towards robust hemocompatibility and bactericidal activity10.1039/D1TB00021G ↗
16. A multi-in-one strategy with glucose-triggered long-term antithrombogenicity and sequentially enhanced endothelialization for biological valve leaflets10.1016/j.biomaterials.2021.120981 ↗
17. Ligation technologies for the synthesis of cyclic peptides10.1021/acs.chemrev.8b00657 ↗
18. Genetic engineering modification and fermentation optimization for extracellular production of recombinant proteins using Escherichia coli10.1007/s00253-017-8700-z ↗
19. Bioactive peptides and proteases: characteristics, applications and the simultaneous production in solid-state fermentation
20. Characterization by high-resolution crystal structure analysis of a triple-helix region of human collagen type III with potent cell adhesion activity10.1016/j.bbrc.2018.12.018 ↗
21. Intravaginal administration of human type III collagen-derived biomaterial with high cell-adhesion activity to treat vaginal atrophy in rats10.1021/acsbiomaterials.9b01649 ↗
22. Platelet collagen receptors, signaling and antagonism: emerging approaches for the prevention of intravascular thrombosis10.1016/j.thromres.2007.10.005 ↗
23. Platelet adhesion to collagen10.1016/S0049-3848(10)70151-1 ↗
24. The Collagen-binding A-domains of Integrins α1β1 and α2β1recognize the same specific amino acid sequence, GFOGER, in native (Triple-helical) collagens10.1074/jbc.275.1.35 ↗
25. Production of recombinant collagen: state of the art and challenges10.1049/enb.2017.0003 ↗
26. Collagen extraction process
27. Quartz crystal microbalance with dissipation monitoring of supported lipid bilayers on various substrates10.1038/nprot.2010.65 ↗
28. Catechol-mediated and copper-incorporated multilayer coating: an endothelium-mimetic approach for blood-contacting devices10.1016/j.jconrel.2020.02.002 ↗
29. Polyzwitterion-crosslinked hybrid tissue with antithrombogenicity, endothelialization, anticalcification properties
30. Green tea polyphenol induced Mg2+-rich multilayer conversion coating: toward enhanced corrosion resistance and promoted in situ endothelialization of AZ31 for potential cardiovascular applications10.1021/acsami.9b17221 ↗
31. Micelle-embedded layer-by-layer coating with catechol and phenylboronic acid for tunable drug loading, sustained release, mild tissue response, and selective cell fate for Re-endothelialization10.1021/acsami.9b01253 ↗
32. Corrosion-controlling and osteo-compatible Mg ion-integrated phytic acid (Mg-pa) coating on magnesium substrate for biodegradable implants application10.1021/am506741d ↗
33. Smooth muscle cell fate and plasticity in atherosclerosis10.1093/cvr/cvy022 ↗
34. Late endothelial progenitor cell-capture stents with CD146 antibody and nanostructure reduce in-stent restenosis and thrombosis10.1016/j.actbio.2020.05.011 ↗
35. Drug-eluting stents in preclinical studies updated consensus recommendations for preclinical evaluation10.1161/CIRCINTERVENTIONS.108.789974 ↗
36. LBL coating of type I collagen and hyaluronic acid on aminolyzed PLLA to enhance the cell-material interaction10.3144/expresspolymlett.2014.36 ↗
37. Natural polyelectrolyte films based on layer-by layer deposition of collagen and hyaluronic acid10.1016/j.biomaterials.2004.08.019 ↗
38. Near-infrared excited orthogonal emissive upconversion nanoparticles for imaging-guided on-demand therapy10.1021/acsnano.9b04200 ↗
39. Surface functionalized hollow manganese oxide nanoparticles for cancer targeted siRNA delivery and magnetic resonance imaging10.1016/j.biomaterials.2010.09.039 ↗
40. In situ XPS study of the surface chemistry of MAPI solar cells under operating conditions in vacuum10.1039/C8CP01259H ↗
41. Fabrication and characterization of superhydrophilic and antibacterial surfaces by silver nanoparticle self-assembly10.1007/s00396-017-4179-5 ↗
42. A stage-specific cell-manipulation platform for inducing endothelialization on demand10.1093/nsr/nwz188 ↗
43. Fabrication of mixed-charge polypeptide coating for enhanced hemocompatibility and anti-infective effect10.1021/acsami.9b19335 ↗
44. Endothelial cell repopulation after stenting determines in-stent neointima formation: effects of bare-metal vs. drug-eluting stents and genetic endothelial cell modification10.1093/eurheartj/ehs240 ↗
45. Hyaluronan promotes the regeneration of vascular smooth muscle with potent contractile function in rapidly biodegradable vascular grafts10.1016/j.biomaterials.2020.120226 ↗
46. Physical effects of cholesterol on arterial smooth muscle membranes: evidence of immiscible cholesterol domains and alterations in bilayer width during atherogenesis10.1016/S0022-2275(20)33861-X ↗
47. The importance of the endothelium in atherothrombosis and coronary stenting10.1038/nrcardio.2012.64 ↗
48. Rapamycin maintains the chondrocytic phenotype and interferes with inflammatory cytokine induced processes10.3390/ijms18071494 ↗
49. Contribution of monocyte-derived macrophages and smooth muscle cells to arterial foam cell formation10.1093/cvr/cvs094 ↗
50. Engineering blood vessels through micropatterned co-culture of vascular endothelial and smooth muscle cells on bilayered electrospun fibrous mats with pDNA inoculation10.1016/j.actbio.2014.10.004 ↗
51. Endothelialization of arterial vascular grafts by circulating monocytes10.1038/s41467-020-15361-2 ↗